Receptor mas protects mice against hypothermia and mortality induced by endotoxemia

Shock

Volumn 41, Issue 4, 2014, Pages 331-336

  Souza, Laura L ^a,b,c,d   Duchene, Johan ^a,b   Todiras, Mihail ^a,b   Azevedo, Luciano C P ^d   Costa Neto, Claudio M ^c   Alenina, Natalia ^a,b   Santos, Robson A ^e   Bader, Michael ^a,b,e  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL SÍRIO LIBANÊS   (Brazil)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Angiotensin 1 7; Body temperature; Cytokines; Inflammation; Lipopolysaccharide; Macrophages

Indexed keywords

ANGIOTENSIN[1-7]; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; RECEPTOR MAS; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN I (1-7); AUTACOID; CYTOKINE; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; ENDOTOXEMIA; HYPOTHERMIA; MALE; MORTALITY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; SURVIVAL RATE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COMPLICATION; DEFICIENCY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANGIOTENSIN I; ANIMALS; CELLS, CULTURED; CYTOKINES; ENDOTOXEMIA; HYPOTHERMIA; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84897068627     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000115     Document Type: Article

References (42)

1. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T: International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
2. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, et al.: A novel angiotensinconverting enzyme-related carboxypeptidase (ACE2) converts angiotensin 1 to angiotensin 1-9. Circ Res 87:e1-e9, 2000.
3. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ: A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243, 2000.
4. Santos RAS, Simoes e Silva AC, Maric C, Silva DMR, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SVB, Lopes MT, Bader M, et al.: Angiotensin- (1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100: 8258-8263, 2003.
5. Metzger R, Bader M, Ludwig T, Berberich C, Bunnemann B, Ganten D: Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett 357: 27-32, 1995.
6. Brosnihan KB, Li P, Ferrario CM: Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27: 523-528, 1996.
7. Kostenis E, Milligan G, Christopoulos A, Sanchez-Ferrer CF, Heringer-Walther S, Sexton PM, Gembardt F, Kellett E, Martini L, Vanderheyden P, et al.: G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111: 1806-1813, 2005.
8. Bader M: ACE-2, angiotensin-(1-7), and Mas: the other side of the coin. Pflügers Archiv Eur J Physiol 465: 79-85, 2012.
9. Chen L-N, Yang X-H, Nissen DH, Chen Y-Y, Wang L-J, Wang J-H, Gao J-L, Zhang L-Y: Dysregulated renin-angiotensin system contributes to acute lung injury caused by hind-limb ischemia-reperfusion in mice. Shock 40: 420-429, 2013.
10. Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RAK, Thaiss F: Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int 61: 1986-1995, 2002.
11. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Rupérez M, Egido J: Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10: 321-329, 2001.
12. Santos RAS, Ferreira AJ, Verano-Braga T, Bader M: Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J Endocrinol 216:R1-R17, 2013.
13. Da Silveira KD, Coelho FM, Vieira AT, Sachs D, Barroso LC, Costa VV, Bretas TLB, Bader M, de Sousa LP, da Silva TA, et al.: Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J Immunol 185: 5569-5576, 2010.
14. El-Hashim AZ, Renno WM, Raghupathy R, Abduo HT, Akhtar S, Benter IF: Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-.B-dependent pathways. Br J Pharmacol 166: 1964-1976, 2012.
15. Wösten-van Asperen RM, Lutter R, Specht PA, Moll GN, Van Woensel JB, van der Loos CM, van Goor H, Kamilic J, Florquin S, Bos AP: Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J Pathol 225: 618-627, 2011.
16. Souza LL, Costa-Neto CM: Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages. J Cell Physiol 227: 2117-2122, 2012.
17. Walther T, Balschun D, Voigt JP, Fink H, Zuschratter W, Birchmeier C, Ganten D, Bader M: Sustained long-term potentiation and anxiety in mice lacking the Mas protooncogene. J Biol Chem 273: 11867-11873, 1998.
18. Davies JQ, Gordon S: Isolation and culture of murine macrophages. Methods Mol Biol 290: 91-103, 2005.
19. Benter IF, Yousif MHM, Anim JT, Cojocel C, Diz DI: Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Am J Physiol Heart Circ Physiol 290:H684-H691, 2006.
20. Dilauro M, Zimpelmann J, Robertson SJ, Genest D, Burns KD: Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am J Physiol Renal Physiol 298:F1523-F1532, 2010.
21. Romanovsky AA, Shido O, Sakurada S, Sugimoto N, Nagasaka T: Endotoxin shock: thermoregulatory mechanisms. Am J Physiol Regul Integr Comp Physiol 270:R693-R703, 1996.
22. Thomas MC, Pickering RJ, Tsorotes D, Koitka A, Sheehy K, Bernardi S, Toffoli B, Nguyen-Huu T-P, Head GA, Fu Y, et al.: Genetic ACE2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ Res 107: 888-897, 2010.
23. Lovren F, Pan Y, Quan A, Teoh H, Wang G, Shukla PC, Levitt KS, Oudit GY, Al-Omran M, Stewart DJ, et al.: Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am J Physiol Heart Circ Physiol 295:H1377-H1384, 2008.
24. Tesanovic S, Vinh A, Gaspari TA, Casley D, Widdop RE: Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arteriosc Thromb Vasc Biol 30: 1606-1613, 2010.
25. Thatcher SE, Gupte M, Hatch N, Cassis LA: Deficiency of ACE2 in bonemarrow- derived cells increases expression of TNF-! in adipose stromal cells and augments glucose intolerance in obese C57BL/6 Mice. Int J Hypertens 2012:762094, 2012.
26. Liu Z, Huang XR, Chen H-Y, Penninger JM, Lan HY: Loss of angiotensinconverting enzyme 2 enhances TGF-"/Smad-mediated renal fibrosis and NF- .B-driven renal inflammation in a mouse model of obstructive nephropathy. Lab Invest 92: 650-661, 2012.
27. Jin H-Y, Song B, Oudit GY, Davidge ST, Yu H-M, Jiang Y-Y, Gao P-J, Zhu D-L, Ning G, Kassiri Z, et al.: ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production. PloS ONE 7:e38502, 2012.
28. Esteban V, Heringer-Walther S, Sterner-Kock A, De Bruin R, Van den Engel S, Wang Y, Mezzano S, Egido J, Schultheiss H-P, Ruiz-Ortega M, et al.: Angiotensin-( 1-7) and the g protein-coupled receptor MAS are key players in renal inflammation. PloS ONE 4:e5406, 2009.
29. Da Silveira KD, Pompermayer Bosco KS, Diniz LRL, Carmona AK, Cassali GD, Bruna-Romero O, de Sousa LP, Teixeira MM, Santos RAS, Simões e Silva AC, et al.: ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats. Clin Sci 119: 385-394, 2010.
30. Santos SHS, Fernandes LR, Pereira CS, Guimarães ALS, De Paula AMB, Campagnole-Santos MJ, Alvarez-Leite JI, Bader M, Santos RAS: Increased circulating angiotensin-(1-7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet. Regul Peptides 178: 64-70, 2012.
31. Sanchez-Lemus E, Murakami Y, Larrayoz-Roldan IM, Moughamian AJ, Pavel J, Nishioku T, Saavedra JM: Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland. Endocrinology 149: 5177-5188, 2008.
32. Hagiwara S, Iwasaka H, Matumoto S, Hidaka S, Noguchi T: Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Crit Care Med 37: 626-633, 2009.
33. Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM: Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43: 970-976, 2004.
34. Rabelo LA, Alenina N, Bader M: ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease. Hypertens Res 34: 154-160, 2011.
35. Brunialti MKC, Martins PS, Barbosa de Carvalho H, Machado FR, Barbosa LM, Salomao R: TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 25: 351-357, 2006.
36. Salomao R, Brunialti MKC, Rapozo MM, Baggio-Zappia GL, Galanos C, Freudenberg M: Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock 38: 227-242, 2012.
37. Lee JY, Lowell CA, Lemay DG, Youn HS, Rhee SH, Sohn KH, Jang B, Ye J, Chung JH, Hwang DH: The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4. Biochem Pharmacol 70: 1231-1240, 2005.
38. Smolinska MJ, Horwood NJ, Page TH, Smallie T, Foxwell BMJ: Chemical inhibition of Src family kinases affects major LPS-activated pathways in primary human macrophages. Mol Immunol 45: 990-1000, 2008.
39. Remick DG, Bolgos G, Copeland S, Siddiqui J: Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun 73: 2751-2757, 2005.
40. Xiao H, Remick DG: Correction of perioperative hypothermia decreases experimental sepsis mortality by modulating the inflammatory response. Crit Care Med 33: 161-167, 2005.
41. Clemmer TP, Fisher CJ, Bone RC, Slotman GJ, Metz CA, Thomas FO: Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med 20: 1395-1401, 1992.
42. Ferreira AJ, Bader M, Santos RAS: Therapeutic targeting of the angiotensinconverting enzyme 2/angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review. Exp Opin Ther Pat 22: 567-574, 2012.